TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Scandinavian Biopharma Distribution AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
161,993
|
156,394
|
115,203 |
| Financial expenses |
598
|
401
|
475 |
| Earnings before taxes |
28,098
|
31,145
|
30,055 |
| EBITDA |
28,126
|
30,805
|
30,464 |
| Total assets |
81,285
|
84,601
|
64,044 |
| Current assets |
81,035
|
83,485
|
63,631 |
| Current liabilities |
22,542
|
26,953
|
26,491 |
| Equity capital |
1,042
|
978
|
898 |
| - share capital |
52
|
51
|
47 |
| Employees (average) |
5
|
4
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
1.3%
|
1.2%
|
1.4% |
| Turnover per employee |
32,399
|
39,098
|
38,401 |
| Profit as a percentage of turnover |
17.3%
|
19.9%
|
26.1% |
| Return on assets (ROA) |
35.3%
|
37.3%
|
47.7% |
| Current ratio |
359.5%
|
309.7%
|
240.2% |
| Return on equity (ROE) |
2696.5%
|
3184.6%
|
3346.9% |
| Change turnover |
2,779
|
33,017
|
26,001 |
| Change turnover % |
2%
|
27%
|
29% |
| Chg. No. of employees |
1
|
1
|
0 |
| Chg. No. of employees % |
25%
|
33%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.